Equifax Inc.’s (NYSE:EFX) Q2 earnings for 2024 exceeded expectations, igniting an uproar of positive reactions among financial analysts.
Goldman Sachs analysts raised their targets from $246 up to $277 while maintaining a neutral stance. Baird saw more potential and increased their target price from $260 up to $290. They maintained an “Outperform” rating.
Needham’s optimism was even greater, as they increased their target price from $305 up to $320 while maintaining the ‘Buy” rating. Oppenheimer, meanwhile, set its sights on $300 from $272 and maintained an “Outperform” rating.
Earnings for Q2
The flurry was triggered by the earnings announcement from Equifax for Q2 2024 on 17th July, where a Non GAAP EPS came in at $1.82 and exceeded expectations by $0.09.
The revenue reported of $1.43bn, while in line with expectations, showed an increase of 8.3% from year to year. The U.S. Mortgage Revenue grew by 4%, despite the 13% drop in USIS mortgage inquiries. This shows resilience in an extremely difficult mortgage market.
Workforce Solutions reported a revenue growth of 5%, driven mainly by the government and talent solution segments.
The international revenue grew by a solid 17% in reported currency terms, and even more so when measured in local currencies, at 28%. Organic growth was a modest 12%.
Equifax has clearly reaped the benefits of strategic use of its new EFX Cloud Platform.
Platform hosted 89% new models and score built with Artificial Intelligence (AI) and Machine Learning. This marked a leap forward in innovation as shown by the 12.5% Vitality Index of new products for the third quarter.
The innovations form part of Equifax’s EFX2026 strategy, which aims to boost the company’s revenue growth and efficiency over time.
Perspective and valuation
Equifax updated its 2024 full-year guidance. The midpoint revenue expectation is $5.720 Billion, which represents an increase of 8.6%, with an adjusted earnings per share of $7.35.
The guidance is based on the projection of a 11% drop in mortgage credit requests in the United States by 2024, along with the expected reduction in cloud expenditure, which will further reduce costs and increase profitability.
Some analysts think that Equifax is overvalued despite these impressive figures.
The authors point out that the high market valuations are due to a combination of optimism and momentum in the markets, even though mortgage rates may be high and economic strength could have been overstated.
Equifax has been able to sustain strong growth in its non-mortgage business, which accounts for roughly 80% percent of the company’s revenue. This provides an alternative narrative to those who are concerned about overvaluation.
Equifax has a good future for scalability, efficiency and scalability thanks to its operational changes and improvements in cloud infrastructure.
It is expected that the company will continue to grow its revenues as it continues to push for more innovative solutions based on data, especially in areas such as government solutions and talent solutions.
After analyzing the business’s fundamentals and determining its growth trajectory, we can now pivot our analysis.
We can now turn to Equifax stock charts and see if its price trend reflects the positive momentum of the fundamentals. This will give us a better idea about the investment potential.
Close above $271.5 is critical
Equifax stock is still trading below the all-time record high of $300 set at the end 2022, despite a 60% increase since last November.
We can see that the peak was briefly broken yesterday, after the release of Q2 results. However, it immediately retraced.
TradingView EFX Chart
This should cause concern for bullish investors. Even though the trend is bullish across all timeframes and the market, it’s not advisable to initiate a position until the stock has a daily close above the bearish trendline. This line currently sits near $271.5.
Investors with a negative outlook should also avoid shorting stocks at the current level and instead wait until they experience a retracement.
Stocks that fall below their 50-day average (currently $242) will indicate short-term weakness. This is the time to initiate a position.
The post Equifax Q2 results in price targets being raised by Goldman Sachs and Needham. Should you purchase? This post may change as new information becomes available
This site is for entertainment only. Click here to read more
